This contract expires in 212 days (Feb 5, 2027).

Browse related active opportunities

PURCHASE ORDER

MEDICAL RESEARCH SUPPORT LLC - THIS IS SERVICE FOR PHASE 1/PHASE 2 OPEN LABEL TRIAL OF A NOVEL INDENOISOQUINOLONE CMYC/TOPOISOMERASE 1 INHIBITOR (LMP744) IN RECURRENT GLIOBLASTOMA. POP: 02/06/2026 TO 02/05/2027.

PIID: 75N95A26P00038
Effective Date: Feb 6, 2026End Date: Closes in 212 days
Award $
$21K
Vendor
MEDICAL RESEARCH SUPPORT LLC

Key Details

Dollars Obligated
$21,450
Awarding Sub-Agency
National Institutes of Health
Place of Performance
MD

Description

THIS IS SERVICE FOR PHASE 1/PHASE 2 OPEN LABEL TRIAL OF A NOVEL INDENOISOQUINOLONE CMYC/TOPOISOMERASE 1 INHIBITOR (LMP744) IN RECURRENT GLIOBLASTOMA. POP: 02/06/2026 TO 02/05/2027.

Context & Analysis

Department of Health and Human Services obligated $21,450 to MEDICAL RESEARCH SUPPORT LLC for this is service for phase 1/phase 2 open label trial of a novel indenoisoquinolone cmyc/topoisomerase 1 inhibitor (lmp744) in recurrent glioblastoma. pop: 02/06/2026 to 02/05/2027.. Performance is located in MD. The contract is scheduled through Feb 5, 2027 — approximately 7 months remaining. This award is one of several similar procurements from Department of Health and Human Services — related awards are listed below.

Contractor Information

UEI: Y5JMG3517VM7
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related